Amarin Corp Plc (AMRN)

[Hspooner]

Amarin will settle and here is why. Currently there is not a multibillion dollar market for icosapent ethyl and without the marketing muscle to build it into a multibillion dollar brand the generics will have a very immature product. They will have ultra thin margins and lots of competition with no incentive to market it, without helping the competition. Generics strategy has always been to swoop in when a branded drug is at or near its peak and start selling their own version at a discounted price to the branded drug. IMO, the generics would be shooting themselves in the foot if they actually wanted to start selling icosapent ethyl now.